Nasdaq
$9.62▲ 1.80%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $270.8MShares out 28.1M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
5- 2d agoAfter-hours26.10.23 06:156-KKey event#●●●#●●●
Vicore Pharma Holding ABBullish
Vicore Pharma's Phase 2b ASPIRE trial for buloxibutid in idiopathic pulmonary fibrosis has successfully passed an independent Data Monitoring Committee's pre-planned futility analysis. The committee recommended continuing the trial without modification, and the company remains on track to report 52-week topline results in mid-2027. With 378 patients fully enrolled, the company confirms it has sufficient cash runway to operate into the second half of 2028.…more
$9.62+1.80%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.13After-hours26.10.14 05:05SCHEDULE 13GOwnership
Vicore Pharma Holding AB
HBM Healthcare Investments (Cayman) Ltd. has filed a Schedule 13G regarding its beneficial ownership in Vicore Pharma Holding AB. This filing serves to formally disclose the investor's stake in the company.…more
$9.62+1.80%vs prev closeView filingShare - 9.30After-hours26.10.01 06:026-KKey event
Vicore Pharma Holding AB
Vicore Pharma has issued 118,916 new shares following the exercise of warrants under its employee incentive programs (Board LTIP 2023, 2024, and RSU 2025). As a result, the total number of outstanding shares and votes has increased to 281,644,509.…more
$9.62+1.80%vs prev closeView filingShare
4 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswireNo news collected yet. New articles will appear here.